(HealthDay)—Using the donated blood plasma of COVID-19 survivors to treat patients in the throes of severe coronavirus illness has met with some controversy. But a small new study suggests it could have real merit.
Sep 15, 2020
0
3
Richard Beckerson will never know whether it was convalescent plasma that made the lifesaving difference—or whether it was the antiviral drug remdesivir or a combination of both.
Sep 11, 2020
0
9
Early findings from researchers at Children's Hospital of Philadelphia (CHOP) show that convalescent plasma appears to be a safe and possibly effective treatment for children with life-threatening cases of COVID-19. The results ...
Sep 8, 2020
0
5
Mohamed Fathi, an Egyptian man who has recovered from COVID-19, winced as he watched tubes running down his arm to donate blood plasma, but insisted: "if I can help just one person, that's a very good thing".
Sep 8, 2020
0
4
On the eve of the Republican National Convention, Food and Drug Administration Commissioner Dr. Stephen Hahn announced that the FDA had issued emergency use authorization for investigational convalescent plasma as a treatment ...
Aug 27, 2020
0
1
Despite the wave of criticism that has followed the U.S. Food and Drug Administration's emergency approval of convalescent plasma to treat COVID-19 patients, infectious disease experts say the therapy remains promising.
Aug 26, 2020
0
11
The United States has issued an emergency authorization to use blood plasma from recovered COVID-19 patients as a treatment against the disease.
Aug 25, 2020
1
4
Imagine going to the doctor for a cough and getting a transfusion of blood from a goat. It probably sounds strange today, but that is exactly how antibody therapy started in the late 1800s.
Aug 21, 2020
0
2
Mayo Clinic researchers reported a strong hint that blood plasma from COVID-19 survivors helps other patients recover, but it's not proof and some experts worry if, amid clamor for the treatment, they'll ever get a clear ...
Aug 14, 2020
0
189
Convalescent plasma has been introduced to the AustralaSian COVID-19 Trial (ASCOT) and Randomized, Embedded, Multi-factorial, Adaptive Platform Trial for Community-Acquired Pneumonia (REMAP-CAP) clinical trials in a bid to ...
Jul 30, 2020
0
2
